论文部分内容阅读
第13届早期乳腺癌全身治疗的专家共识会议于2013年3月在瑞士的St.Gallen召开,有来自94个国家从事乳腺癌诊治的医务工作者参加了本次会议。会议内容主要是结合目前循证医学证据和最新进展,就乳腺癌病人推荐一个较为合理的治疗方案。目前已知乳腺癌至少包含腔内细胞(Luminal)A型、Luminal B型、HER2阳性型和三阴性型4个亚型~([1])。在临床诊治过程中,需针对不同亚型的乳腺癌病人
The 13th consensus meeting on systemic treatment of early breast cancer was held in St.Gallen, Switzerland, in March 2013. Medical workers from 94 countries engaged in the diagnosis and treatment of breast cancer participated in this meeting. The main content of the meeting is combined with the current evidence-based evidence and the latest advances in breast cancer patients recommended a more reasonable treatment. It is known that breast cancer contains at least 4 subtypes of luminal A, Luminal B, HER2 positive and triple negative [~ 1]. In the clinical diagnosis and treatment process, need to target different subtypes of breast cancer patients